MeAgain is built for the larger GLP-1 job: shot day, injection sites, food, protein, fiber, water, side effects, weight, progress photos, medication context, Journey Cards, Capy, and daily support in one place
Tirzepatide is an FDA-approved medication originally developed to treat type 2 diabetes and is now widely used off-label for medical weight loss due to its powerful metabolic effects
More research is needed to study potential short- and long-term risks across a broader population, which is why GLP-1s are generally not recommended for breastfeeding women
Diabetes-related gastroparesis is a type of diabetes-related neuropathy